Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
基本信息
- 批准号:7340730
- 负责人:
- 金额:$ 26.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-15 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntibody FormationAntigen PresentationAntigen-Antibody ComplexAntigensAppearanceB-LymphocytesBacteriophagesBindingBinding SitesBiochemicalBlood CirculationCytoplasmic TailDataDendritic CellsEpithelial CellsFc ReceptorFigs - dietaryFollicular Dendritic CellsGene TargetingGenesGlycoproteinsGoalsHandHematopoieticHumanImmunoglobulin AImmunoglobulin MImmunoglobulinsIntestinesKidneyLeucineLigandsLinkLymphoid TissueMembraneMessenger RNAMolecularMucosal ImmunityMusNaturePaneth CellsPlayPolymeric Immunoglobulin ReceptorsProteinsRNA SplicingRoleSerineSideStructureStructure of germinal center of lymph nodeStructure-Activity RelationshipSystemTestingThreonineTissuesTonsilTransfectionTranslatingTubular formationTyrosineUrineVariantcell typecomparativeextracellularin vivointerestintestinal cryptmacrophagemicroorganism antigenmonocytemouse modelnovelprotein expressionreceptorreceptor internalizationresearch study
项目摘要
DESCRIPTION (provided by applicant): The overall goal of these studies is to define the structure/function relationship of a recently identified Fc receptor for IgA and IgM (Fcalpha/muR). The Ig-like domain at the amino terminus of the predicted Fcalpha/muR glycoprotein contains a sequence motif that is conserved in the polymeric Ig receptor of various species and is predicted to be the binding site for IgM and IgA. The Fcalpha/muR gene is expressed in both hematopoietic (B and monocyte/macrophages) and non-hematopoietic (kidney and intestine) tissues in both humans and mice. Preliminary studies of Fcalpha/muR expression in humans indicate an interesting cellular distribution: germinal centers with the appearance of follicular dendritic cells (FDC) in tonsil, proximal tubular epithelial cells in kidney and Paneth cells in small intestinal crypts. Unlike the mouse Fcalpha/muR, the human receptor is expressed only by the B cells that reside in secondary lymphoid tissues rather than those present in the circulation. A novel splice variant that is predicted to encode a soluble form of Fcalpha/muR has been identified in the kidney. These findings have led to the hypothesis that Fcalpha/muR plays multiple functional roles depending upon the cell types expressing it. Fcalpha/muR on FDC may trap IgM or IgA immune complexes and present the intact antigens to B cells in germinal centers. Fcalpha/muR expression by B cells may be closely linked with cellular activation. On the other hand, Fcalpha/muR in renal tubular epithelial cells and intestinal Paneth cells may play a protective role at portals of entry for antigens and microorganisms. These hypotheses will be tested through the following Specific Aims: 1) Determine the cellular distribution and molecular nature of Fcalpha/muR by using receptor-specific antibodies and Ig-ligands; 2) Define the newly identified Fcalpha/muR splice variant as a soluble form of receptor; 3) Determine the function of the membrane-bound Fcalpha/muR; and 4) Employ an Fcalpha/muR-deficient mouse model to explore the in vivo function of the Fca/alphaR.
描述(由申请人提供):这些研究的总体目标是定义IGA和IGM最近确定的FC受体的结构/功能关系(FCALPHA/MUR)。预测的fcalpha/mUR糖蛋白的氨基末端的Ig样结构域包含一个序列基序,该基序在各种物种的聚合物Ig受体中保守,并被预测为IgM和IgA的结合位点。 FCALPHA/MUR基因在人类和小鼠的造血(B和单核细胞/巨噬细胞)和非脊髓质(肾脏和肠道)组织中均表达。人类FCALPHA/MUR表达的初步研究表明了一个有趣的细胞分布:扁桃体中卵泡树突状细胞(FDC)出现的生发中心,肾脏近端肾小管上皮细胞中的肾脏和小肠隐窝中的Paneth细胞。与小鼠FCALPHA/MUR不同,人体受体仅由驻留在次级淋巴组织中而不是循环中存在的B细胞表达。在肾脏中发现了一种新型的剪接变体,该变体被预测,该变体可以编码一种可溶性的FCalpha/MUR形式。这些发现导致了以下假设:FCALPHA/MUR起着多种功能作用,具体取决于表达的细胞类型。 FDC上的FCALPHA/MUR可能会捕获IgM或IgA免疫复合物,并将完整的抗原呈现给生发中心的B细胞。 B细胞的FCALPHA/MUR表达可能与细胞活化密切相关。另一方面,肾小管上皮细胞和肠道细胞中的FCALPHA/MUR可能在抗原和微生物的入口处发挥保护作用。这些假设将通过以下特定目的进行检验:1)通过使用受体特异性抗体和Ig-凸质确定FCALPHA/MUR的细胞分布和分子性质; 2)将新鉴定的FCalpha/MUR剪接变体定义为一种可溶性形式的受体形式; 3)确定膜结合的FCALPHA/MUR的功能; 4)采用FCALPHA/MIR缺陷小鼠模型来探索FCA/alphar的体内功能。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The long elusive IgM Fc receptor, FcμR.
- DOI:10.1007/s10875-014-0022-7
- 发表时间:2014-07
- 期刊:
- 影响因子:9.1
- 作者:Kubagawa H;Oka S;Kubagawa Y;Torii I;Takayama E;Kang DW;Jones D;Nishida N;Miyawaki T;Bertoli LF;Sanders SK;Honjo K
- 通讯作者:Honjo K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hiromi Kubagawa其他文献
Hiromi Kubagawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hiromi Kubagawa', 18)}}的其他基金
Studies of Paired Immunoglobulin-Like Receptors
配对免疫球蛋白样受体的研究
- 批准号:
8082003 - 财政年份:2010
- 资助金额:
$ 26.97万 - 项目类别:
Studies of structure and function of an Fc receptor for IgM
IgM Fc 受体的结构和功能研究
- 批准号:
8091880 - 财政年份:2010
- 资助金额:
$ 26.97万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
7018461 - 财政年份:2004
- 资助金额:
$ 26.97万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
7179263 - 财政年份:2004
- 资助金额:
$ 26.97万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
6850789 - 财政年份:2004
- 资助金额:
$ 26.97万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
6773549 - 财政年份:2004
- 资助金额:
$ 26.97万 - 项目类别:
NOVEL PAIR OF IMMUNOGLOBULIN LIKE RECEPTORS IN MICE
小鼠体内的一对新型免疫球蛋白样受体
- 批准号:
6510761 - 财政年份:1998
- 资助金额:
$ 26.97万 - 项目类别:
Studies of Paired Immunoglobulin-Like Receptors
配对免疫球蛋白样受体的研究
- 批准号:
7074633 - 财政年份:1998
- 资助金额:
$ 26.97万 - 项目类别:
相似国自然基金
Tfh细胞调节自身抗体形成在溃疡性结肠炎体液免疫应答中的作用
- 批准号:81170361
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
胞内化抗体介导的HBcAg去功能化抑制HBV核壳体形成的机制研究
- 批准号:81070335
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
老年性和致病性II型胶原位点自身抗体形成机理探讨
- 批准号:39870857
- 批准年份:1998
- 资助金额:11.0 万元
- 项目类别:面上项目
相似海外基金
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
- 批准号:
10658665 - 财政年份:2023
- 资助金额:
$ 26.97万 - 项目类别:
Improving the Immune Response to Nanoparticle-Based SARS-CoV-2 Vaccines
改善基于纳米颗粒的 SARS-CoV-2 疫苗的免疫反应
- 批准号:
10648704 - 财政年份:2023
- 资助金额:
$ 26.97万 - 项目类别:
Pathogenic B cell:CD4 T cell interactions in a novel B cell-dependent EAE mouse model of multiple sclerosis
致病性 B 细胞:CD4 T 细胞在新型 B 细胞依赖性多发性硬化症 EAE 小鼠模型中的相互作用
- 批准号:
10718277 - 财政年份:2023
- 资助金额:
$ 26.97万 - 项目类别:
The role of B-cells in the anti-tumor immune response in triple negative breast cancer
B 细胞在三阴性乳腺癌抗肿瘤免疫反应中的作用
- 批准号:
10370170 - 财政年份:2022
- 资助金额:
$ 26.97万 - 项目类别: